Sbc Medical Group Holdings Incorporated (SBC) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sbc Medical Group Holdings Incorporated  (NASDAQ: SBC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Sbc Medical Group Holdings Incorporated's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sbc Medical Group Holdings Incorporated's ROA in the second quarter of 2026?
Sbc Medical Group Holdings Incorporated achieved a return on average assets (ROA) of 13.1 % in its second quarter of 2026, which is below Sbc Medical Group Holdings Incorporated's average return on assets, which stands at 22.93%.

Despite the company's net income deteriorating, Sbc Medical Group Holdings Incorporated was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 73 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 378 to 513.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 24.48 % 36.34 % 54.34 % 15.94 % 1574.8 %
Y / Y Net Income Change 357.5 % -47.29 % -67.88 % 352.76 % -86.8 %
Net Income (TTM) in million 50 41 51 81 71
Return On Assets (TTM) 13.1 % 11.39 % 15.33 % 27.09 % 24.73 %
SBC's Total Ranking # 513 # 378 # 159 # 182 # 109
Total Assets (TTM) in million 405 388 376 346 326
Seq. Total Assets Change 4.47 % 3.28 % 8.65 % 6.19 % 14.42 %
Seq. Net Income Change -1.47 % -20.66 % 11.27 % 425.99 % -88.65 %

SBC's 5 Years Annual ROA >> Back to SBC Management Effectiveness >> Compare SBC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 2
Sector # 74
Overall # 425

Return On Assets Statistics
High Average Low
56.62 %
22.93 %
0.68 %
(Jun 30 2024)   (Mar 31 2023)



  News about Sbc Medical Group Holdings Incorporated Return on Assets ROA

SBC Medical Innovates with Translation App While Facing Market Challenges

In a bid to enhance communication in the field of aesthetic medicine, SBC Medical Group Holdings Incorporated has launched a specialized translation application aimed at bridging the language gap between practitioners and patients. This innovative initiative comes as part of the company’s broader strategy to strengthen its Inbound-Focused Clinics program, which emphasizes patient-centered care and elevating the overall client experience in aesthetic treatments.The new application is designed to ensure that patients, regardless of their linguistic background, can fully understand the procedures, benefits, and potential risks associated with aesthetic treatments. By removing language barriers, SBC Medical hopes to bolster patient confidence and satisfaction, thereby improving outcomes and fostering a more inclusive environment within the industry.



Financial Statements
Sbc Medical Group Holdings Incorporated's Assets $ 405 million SBC's Balance sheet
Sbc Medical Group Holdings Incorporated's Income $ 11 million Quarterly SBC's Income Statement
SBC's Income by Division See SBC's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022
FY
Y / Y Total Assets Change 26.46 % 960.1 % -82.25 % - -
Total Assets in million 285 225 21 120 0
Y / Y Net Income Change 9.33 % 13641.74 % -38.54 % - -
Net Income in million 51 47 0 1 0
Annual Return On Assets 17.92 % 20.73 % 1.6 % 0.46 % -

SBC's 5 Years Annual ROA >> Back to SBC Management Effectiveness >> Compare SBC ROA to its Competitors



Comment on SBC's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 17.92 %, despite annual net income growth of 9.33 % to $51.05 million, from $46.69 million a year ago, as SBC's assets increase to $284.83 million, by 9.33 %.


More Return On Assets Ratios
SBC's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SBC's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SBC's Competitors
Subscribers only: Roa for Sbc Medical Group Holdings Incorporated's Suppliers
Subscribers only: Return On Assets for SBC's Customers

You may also want to know
SBC's Roi SBC's Inventory Turnover Ratio SBC's Growth Rates SBC's Dividend Comparisons
SBC's Profitability Ratios SBC's Asset Turnover Ratio SBC's Dividend Growth
SBC's Roe SBC's Valuation Ratios SBC's Financial Strength Ratios SBC's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Ironwood Pharmaceuticals inc   34.34 %
Idexx Laboratories Inc  33.61 %
Tg Therapeutics Inc   33.59 %
Meiragtx Holdings Plc  29.37 %
Indivior Pharmaceuticals Inc   28.21 %
Qhslab Inc   27.12 %
Adma Biologics Inc   26.58 %
Mettler toledo International Inc   24.86 %
Medpace Holdings Inc   24.84 %
Caredx Inc   24.81 %
Acadia Pharmaceuticals Inc   24.38 %
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %

Date modified: 2026-09-12T06:26:47+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.